OXIDATION OF THE PHOSPHINE FROM THE AURANOFIN ANALOG, TRIISOPROPYLPHOSPHINE(2,3,4,6-TETRA-O-ACETYL-1-THIO-BETA-D-GLUCOPYRANOSATO-S)GOLD(I), VIA A PROTEIN-BOUND PHOSPHONIUM INTERMEDIATE

被引:47
作者
SHAW, CF
ISAB, AA
HOESCHELE, JD
STARICH, M
LOCKE, J
SCHULTEIS, P
XIAO, J
机构
[1] UNIV MICHIGAN,DEPT CHEM,ANN ARBOR,MI 48109
[2] UNIV WISCONSIN,DEPT MED,MILWAUKEE,WI 53201
关键词
D O I
10.1021/ja00085a003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The reactions of serum albumin, a blood carrier of gold(I), with the auranofin analogue triisopropylphosphine(2,3,4,6-tetra-Q-acetyl-1-thio-beta-D-glucopyranosato-S)gold(I) (i-Pr3PAuSATg) and free triisopropylphosphine have been studied in buffered aqueous solution using {H-1}P-31 NMR and chromatographic methods. Triisopropylphosphine (i-Pr3P) is oxidized to i-Pr3PS Via an albuminthiolatotriisopropylphosphonium ion, i-Pr3p+SCH2(HSCH2)Alb, which is formed by attack on a protein disulfide bond. This species is the key intermediate in the albumin-driven conversion of a phosphine ligand (e.g., from auranofin or an analogue) into phosphine oxide or phosphine sulfide. i-Pr3p+SCH2-(HSCH2)Alb, which is characterized by a P-31 NMR chemical shift of 75.4 ppm, forms quickly and then reacts slowly (k(obs) = (6.9 +/- 0.6) x 10(-5) s-1) to form i-Pr3PS and a small quantity of i-Pr3PO. The auranofin analogues i-Pr3PAuSATg and i-Pr3PAuCl, react with serum albumin at cysteine-34 to form AlbSAuPi-Pr3 via displacement of the anions. i-Pr3PAuCl reacts further at weak binding sites analogous to the histidine binding sites of auranofin. In contrast to the displacement of Et3P from AlbSAuPEt3 by thiols, cyanide is required to displace i-Pr3P from AlbSAuPi-Pr3. The liberated i-Pr3P also reacts via the alubminphosphonium intermediate described above to form i-P3PS and traces of i-P3PO. In order to interpret the protein studies, a variety of potential reaction products (i-Pr3PAuX, X = CN, ATgS, Cl; i-Pr3PY, Y = O, S) were prepared and characterized by P-31 NMR spectroscopy. Model reactions of i-Pr3PAuX (X = Cl, ATgS) with cyanide are also reported.
引用
收藏
页码:2254 / 2260
页数:7
相关论文
共 32 条
[1]  
Berners-Price S., 1988, STRUCT BOND, V70, P27
[2]  
COFFER MT, 1986, INORG CHEM, V25, P333
[3]   THIOL COMPETITION FOR ET3PAUS-ALBUMIN - A NONENZYMATIC MECHANISM FOR ET3PO FORMATION [J].
COFFER, MT ;
SHAW, CF ;
HORMANN, AL ;
MIRABELLI, CK ;
CROOKE, ST .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1987, 30 (03) :177-187
[4]  
DHUBHGHAILL OMN, 1992, J AM CHEM SOC, V114, P1118
[5]   REACTIONS OF THE METALLODRUG AURANOFIN [(1-THIO-BETA-D-GLUCOPYRANOSE-2,3,4,6-TETRAACETATO-S)(TRIETHYLPHOSPHINE)GOLD] WITH BIOLOGICAL LIGANDS STUDIED BY RADIOISOTOPE METHODOLOGY [J].
ECKER, DJ ;
HEMPEL, JC ;
SUTTON, BM ;
KIRSCH, R ;
CROOKE, ST .
INORGANIC CHEMISTRY, 1986, 25 (18) :3139-3143
[6]  
ELDER RC, 1993, J RHEUMATOL, V20, P268
[7]  
Espenson J. H., 1981, CHEM KINETICS REACTI, P55
[8]   AURANOFIN - NEW ORAL GOLD COMPOUND FOR TREATMENT OF RHEUMATOID-ARTHRITIS [J].
FINKELSTEIN, AE ;
WALZ, DT ;
BATISTA, V ;
MIZRAJI, M ;
ROISMAN, F ;
MISHER, A .
ANNALS OF THE RHEUMATIC DISEASES, 1976, 35 (03) :251-257
[9]  
GERBER DA, 1964, J PHARMACOL EXP THER, V143, P137
[10]   THE EFFECT OF CYANIDE ON THE UPTAKE OF GOLD BY RED-BLOOD-CELLS [J].
GRAHAM, GG ;
HAAVISTO, TM ;
JONES, HM ;
CHAMPION, GD .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (08) :1257-1262